Charles Schwab Investment Management Inc Reneo Pharmaceuticals, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023
BUY
$5.44 - $8.13 $43,253 - $64,641
7,951 Added 26.91%
37,503 $285,000
Q2 2023

Aug 09, 2023
BUY
$5.44 - $10.5 $160,762 - $310,296
29,552 New
29,552 $193,000
Q2 2022

Aug 15, 2022
SELL
$1.96 - $3.04 $36,906 - $57,243
-18,830 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$6.07 - $9.68 $33,136 - $52,843
5,459 Added 40.83%
18,830 $161,000
Q2 2021

Aug 16, 2021
BUY
$7.78 - $15.0 $104,026 - $200,565
13,371 New
13,371 $125,000

Others Institutions Holding RPHM

# of Institutions
48
Shares Held
30.5M
Call Options Held
50.8K
Put Options Held
0
View Full List

About Reneo Pharmaceuticals, Inc.

RPHM Quotes by TradingView
  • Ticker RPHM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,479,600
  • Market Cap $41.1M
  • Description
  • Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as w...
More about RPHM
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email